FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387661618> ?p ?o ?g. }

• W4387661618 endingPage "S313" @default.
• W4387661618 startingPage "S305" @default.
• W4387661618 abstract "Addressing the treatment and prevention of antibacterial-resistant gram-negative bacterial infections is a priority area of the Antibacterial Resistance Leadership Group (ARLG). The ARLG has conducted a series of observational studies to define the clinical and molecular global epidemiology of carbapenem-resistant and ceftriaxone-resistant Enterobacterales, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii, with the goal of optimizing the design and execution of interventional studies. One ongoing ARLG study aims to better understand the impact of fluoroquinolone-resistant gram-negative gut bacteria in neutropenic patients, which threatens to undermine the effectiveness of fluoroquinolone prophylaxis in these vulnerable patients. The ARLG has conducted pharmacokinetic studies to inform the optimal dosing of antibiotics that are important in the treatment of drug-resistant gram-negative bacteria, including oral fosfomycin, intravenous minocycline, and a combination of intravenous ceftazidime-avibactam and aztreonam. In addition, randomized clinical trials have assessed the safety and efficacy of step-down oral fosfomycin for complicated urinary tract infections and single-dose intravenous phage therapy for adult patients with cystic fibrosis who are chronically colonized with P. aeruginosa in their respiratory tract. Thus, the focus of investigation in the ARLG has evolved from improving understanding of drug-resistant gram-negative bacterial infections to positively affecting clinical care for affected patients through a combination of interventional pharmacokinetic and clinical studies, a focus that will be maintained moving forward." @default.
• W4387661618 created "2023-10-17" @default.
• W4387661618 creator A5000611736 @default.
• W4387661618 creator A5001141136 @default.
• W4387661618 creator A5001559486 @default.
• W4387661618 creator A5006534529 @default.
• W4387661618 creator A5030280540 @default.
• W4387661618 creator A5041183761 @default.
• W4387661618 creator A5045500368 @default.
• W4387661618 creator A5049005652 @default.
• W4387661618 creator A5055269054 @default.
• W4387661618 creator A5061755175 @default.
• W4387661618 creator A5067156920 @default.
• W4387661618 creator A5068286313 @default.
• W4387661618 creator A5077459379 @default.
• W4387661618 creator A5084249121 @default.
• W4387661618 creator A5084558722 @default.
• W4387661618 creator A5089384391 @default.
• W4387661618 creator A5089850098 @default.
• W4387661618 date "2023-10-15" @default.
• W4387661618 modified "2023-10-17" @default.
• W4387661618 title "Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group" @default.
• W4387661618 cites W2096598041 @default.
• W4387661618 cites W2100619015 @default.
• W4387661618 cites W2112189930 @default.
• W4387661618 cites W2119292070 @default.
• W4387661618 cites W2141060073 @default.
• W4387661618 cites W2807575822 @default.
• W4387661618 cites W2883493538 @default.
• W4387661618 cites W2890300667 @default.
• W4387661618 cites W2890837116 @default.
• W4387661618 cites W2991488880 @default.
• W4387661618 cites W2995120671 @default.
• W4387661618 cites W3009858064 @default.
• W4387661618 cites W3031743160 @default.
• W4387661618 cites W3096062952 @default.
• W4387661618 cites W3157374051 @default.
• W4387661618 cites W3161889079 @default.
• W4387661618 cites W3213159307 @default.
• W4387661618 cites W4206677002 @default.
• W4387661618 cites W4220953385 @default.
• W4387661618 cites W4226336548 @default.
• W4387661618 cites W4229453358 @default.
• W4387661618 cites W4286697281 @default.
• W4387661618 cites W4307331189 @default.
• W4387661618 cites W4309244714 @default.
• W4387661618 cites W4309245109 @default.
• W4387661618 cites W4313340059 @default.
• W4387661618 cites W4319661295 @default.
• W4387661618 cites W4322487588 @default.
• W4387661618 cites W4375866204 @default.
• W4387661618 doi "https://doi.org/10.1093/cid/ciad547" @default.
• W4387661618 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37843118" @default.
• W4387661618 hasPublicationYear "2023" @default.
• W4387661618 type Work @default.
• W4387661618 citedByCount "0" @default.
• W4387661618 crossrefType "journal-article" @default.
• W4387661618 hasAuthorship W4387661618A5000611736 @default.
• W4387661618 hasAuthorship W4387661618A5001141136 @default.
• W4387661618 hasAuthorship W4387661618A5001559486 @default.
• W4387661618 hasAuthorship W4387661618A5006534529 @default.
• W4387661618 hasAuthorship W4387661618A5030280540 @default.
• W4387661618 hasAuthorship W4387661618A5041183761 @default.
• W4387661618 hasAuthorship W4387661618A5045500368 @default.
• W4387661618 hasAuthorship W4387661618A5049005652 @default.
• W4387661618 hasAuthorship W4387661618A5055269054 @default.
• W4387661618 hasAuthorship W4387661618A5061755175 @default.
• W4387661618 hasAuthorship W4387661618A5067156920 @default.
• W4387661618 hasAuthorship W4387661618A5068286313 @default.
• W4387661618 hasAuthorship W4387661618A5077459379 @default.
• W4387661618 hasAuthorship W4387661618A5084249121 @default.
• W4387661618 hasAuthorship W4387661618A5084558722 @default.
• W4387661618 hasAuthorship W4387661618A5089384391 @default.
• W4387661618 hasAuthorship W4387661618A5089850098 @default.
• W4387661618 hasConcept C114851261 @default.
• W4387661618 hasConcept C126322002 @default.
• W4387661618 hasConcept C177713679 @default.
• W4387661618 hasConcept C2776315533 @default.
• W4387661618 hasConcept C2777637488 @default.
• W4387661618 hasConcept C2779259085 @default.
• W4387661618 hasConcept C2779631663 @default.
• W4387661618 hasConcept C2780416669 @default.
• W4387661618 hasConcept C501593827 @default.
• W4387661618 hasConcept C523546767 @default.
• W4387661618 hasConcept C54355233 @default.
• W4387661618 hasConcept C71924100 @default.
• W4387661618 hasConcept C86803240 @default.
• W4387661618 hasConcept C89423630 @default.
• W4387661618 hasConcept C94665300 @default.
• W4387661618 hasConceptScore W4387661618C114851261 @default.
• W4387661618 hasConceptScore W4387661618C126322002 @default.
• W4387661618 hasConceptScore W4387661618C177713679 @default.
• W4387661618 hasConceptScore W4387661618C2776315533 @default.
• W4387661618 hasConceptScore W4387661618C2777637488 @default.
• W4387661618 hasConceptScore W4387661618C2779259085 @default.
• W4387661618 hasConceptScore W4387661618C2779631663 @default.
• W4387661618 hasConceptScore W4387661618C2780416669 @default.
• W4387661618 hasConceptScore W4387661618C501593827 @default.

• next